Clinical risk factors for early mortality in patients with community-acquired septic shock. The importance of adequate source control J. Vallés; E. Diaz; J. Carles Oliva; M. Martínez; A. Navas; J. Mesquida; G. Gruartmoner; C. de Haro; J. Mestre; C. Guía; A. Rodriguez; A. Ochagavía;

Enhancing sepsis management through machine learning techniques: A review N. Ocampo-Quintero; P. Vidal-Cortés; L. del Río Carbajo; F. Fdez-Riverola; M. Reboiro-Jato; D. Glez-Peña;

Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial Cássio Mallmann; Thizá Maria Bianchi Galiotto; Michele Salibe de Oliveira; Rafael Barberena Moraes;